99mTc-MAA SPECT/CT 在 90Y 放射性栓塞肺分流估计中的价值:体模与患者研究
本研究通过肝/肺躯干体模和患者数据评估 99mTc-MAA 平面显像与 SPECT/CT 估算肺分流分数(LSF)的准确性与精确性。体模中 SPECT/CT 加衰减和散射校正的 LSF 估计准确度优于平面显像;患者中平面显像显著高估 LSF,SPECT/CT 与 90Y PET/CT 的 LSF 无显著差异。作者认为 99mTc-MAA SPECT/CT 加衰减和散射校正可用于放射性栓塞前的肺分流估计。
要点
- 体模研究中 SPECT/CT 加衰减和散射校正的 LSF 估计与真值偏差在 13% 以内,平面显像高估可达 44%。
- 患者中平面显像显著高估 LSF,SPECT/CT 与 90Y PET/CT 的 LSF 无显著差异(p = 0.968)。
- 接受治疗的 28 例患者平均肺吸收剂量平面显像为 9.3 Gy,SPECT/CT 为 3.2 Gy。
核心结论
- 体模研究显示的准确度改善、患者研究中与 90Y PET/CT 的一致性以及自动勾画定义肝/肺的实用性,提示放射性栓塞前应采用加衰减和散射校正的 99mTc-MAA SPECT/CT 进行肺分流估计。
研究设计与样本
- 体模研究:肝/肺躯干体模填充 99mTc 以达到三种肺分流值,用平面显像和 SPECT/CT 重复采集以评估准确性和精确性。
- 患者研究:回顾性比较 40 例患者病历中的平面显像 LSF 估计与加衰减和散射校正的 SPECT/CT 计算值。
- 患者亚组:20 例患者中比较治疗前估计值与 90Y PET/CT 测量值。
- 实施基于 SPECT 和 CT 的自动勾画定义肝和肺体积的工作流程以处理患者数据。
主要发现
- 体模研究中 SPECT/CT 加衰减和散射校正的 LSF 估计与真值偏差在 13% 以内,平面显像高估可达 44%。
- 患者中平面显像较 SPECT/CT 显著高估 LSF。
- 肺分流估计与 99mTc-MAA 给药至扫描之间的延迟无相关性,但延迟较长的患者更倾向于出现靶外肝外摄取。
- 接受治疗的 28 例患者平均肺吸收剂量预测:平面显像 9.3 Gy(范围 1.3-29.4),SPECT/CT 3.2 Gy(范围 0.4-13.4)。
- 有治疗后影像的患者中,90Y PET/CT 平均 LSF 为 1.0%(范围 0.3-2.8),与 99mTc-MAA SPECT/CT 平均 LSF 1.0%(范围 0.4-1.6)无显著差异(p = 0.968),但显著低于平面显像平均 LSF 4.1%(范围 1.2-15.0;p = 0.0002)。
关键数值与推荐
- 体模中 SPECT/CT 加衰减和散射校正的 LSF 估计与真值偏差在 13% 以内,平面显像高估可达 44%。
- 28 例接受治疗患者平均肺吸收剂量:平面显像 9.3 Gy(范围 1.3-29.4)vs SPECT/CT 3.2 Gy(范围 0.4-13.4)。
- 20 例患者中 90Y PET/CT 平均 LSF 1.0%(范围 0.3-2.8)vs 99mTc-MAA SPECT/CT 平均 LSF 1.0%(范围 0.4-1.6),p = 0.968。
- 90Y PET/CT 平均 LSF 1.0%(范围 0.3-2.8)vs 平面显像平均 LSF 4.1%(范围 1.2-15.0),p = 0.0002。
临床怎么用
- 作者认为放射性栓塞前应采用加衰减和散射校正的 99mTc-MAA SPECT/CT 进行肺分流估计。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A major toxicity concern in radioembolization therapy of hepatic malignancies is radiation-induced pneumonitis and sclerosis due to hepatopulmonary shunting of 90Y microspheres. Currently, 99mTc macroaggregated albumin (99mTc-MAA) imaging is used to estimate the lung shunt fraction (LSF) prior to treatment. The aim of this study was to evaluate the accuracy/precision of LSF estimated from 99mTc planar and SPECT/CT phantom imaging, and within this context, to compare the corresponding LSF and lung-absorbed dose values from 99mTc-MAA patient studies. Additionally, LSFs from pre- and post-therapy imaging were compared. RESULTS: A liver/lung torso phantom filled with 99mTc to achieve three lung shunt values was scanned by planar and SPECT/CT imaging with repeat acquisitions to assess accuracy and precision. To facilitate processing of patient data, a workflow that relies on SPECT and CT-based auto-contouring to define liver and lung volumes for the LSF calculation was implemented. Planar imaging-based LSF estimates for 40 patients, obtained from their medical records, were retrospectively compared with SPECT/CT imaging-based calculations with attenuation and scatter correction. Additionally, in a subset of 20 patients, the pre-therapy estimates were compared with 90Y PET/CT-based measurements. In the phantom study, improved accuracy in LSF estimation was achieved using SPECT/CT with attenuation and scatter correction (within 13% of the true value) compared with planar imaging (up to 44% overestimation). The results in patients showed a similar trend with planar imaging significantly overestimating LSF compared to SPECT/CT. There was no correlation between lung shunt estimates and the delay between 99mTc-MAA administration and scanning, but off-target extra hepatic uptake tended to be more likely in patients with a longer delay. The mean lung absorbed dose predictions for the 28 patients who underwent therapy was 9.3 Gy (range 1.3-29.4) for planar imaging and 3.2 Gy (range 0.4-13.4) for SPECT/CT. For the patients with post-therapy imaging, the mean LSF from 90Y PET/CT was 1.0%, (range 0.3-2.8). This value was not significantly different from the mean LSF estimate from 99mTc-MAA SPECT/CT (mean 1.0%, range 0.4-1.6; p = 0.968), but was significantly lower than the mean LSF estimate based on planar imaging (mean 4.1%, range 1.2-15.0; p = 0.0002). CONCLUSIONS: The improved accuracy demonstrated by the phantom study, agreement with 90Y PET/CT in patient studies, and the practicality of using auto-contouring for liver/lung definition suggests that 99mTc-MAA SPECT/CT with scatter and attenuation corrections should be used for lung shunt estimation prior to radioembolization.
引用
- Allred JD, Niedbala J, Mikell JK, et al. The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study. EJNMMI Res. 2018. PMID: 29904808. doi:10.1186/s13550-018-0402-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。